SCHEMBL756551

SCHEMBL756551

[c]1cccc2cc3[c]cccc3cc12

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.32
ALOX12 P18054 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1044235 0.95 ALDH1A1 (0.32)
SCHEMBL17044573 0.95
SCHEMBL18832 0.92 ALDH1A1 (0.36) CYP2A6ALOX12
SCHEMBL1921671 0.92 ALDH1A1 (0.32) CYP2A6ALOX12
SCHEMBL29033245 0.90 ALDH1A1 (0.39) CYP2A6ALOX12
SCHEMBL15366695 0.90 ALDH1A1 (0.39) CYP2A6ALOX12
SCHEMBL28474556 0.90 ALDH1A1 (0.39) CYP2A6ALOX12
SCHEMBL25147 0.90 ALDH1A1 (0.39) CYP2A6ALOX12
SCHEMBL28997726 0.90 ALDH1A1 (0.39) CYP2A6ALOX12
SCHEMBL27937630 0.88 ALDH1A1 (0.38) CYP2A6ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 446 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210069963-A1 METHOD FOR MANUFACTURING A THREE-DIMENSIONAL OBJECT SOLVAY SPECIALITY POLYMERS USA, LLC 2021-03-11 US claimed
US-10824006-B2 Liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2020-11-03 US claimed
CN-111479874-A Method for producing a three-dimensional object 索尔维特殊聚合物美国有限责任公司 2020-07-31 CN claimed
US-20190324320-A1 LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2019-10-24 US claimed
US-10042207-B2 Liquid crystal display panel and liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2018-08-07 US claimed
CN-108219509-A For the new compound of carrying body 株式会社艾迪科 2018-06-29 CN claimed
US-9983441-B2 Liquid crystal display device MERCK PATENT GMBH (DE) 2018-05-29 US claimed
US-20170343863-A1 LIQUID CRYSTAL DISPLAY PANEL AND LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2017-11-30 US claimed
US-20170199433-A1 TRANSVERSE-ELECTRIC-FIELD LIQUID CRYSTAL DEVICE AND METHOD FOR MANUFACTURING SAME TOYO GOSEI CO., LTD. (JP) 2017-07-13 US claimed
US-9644146-B2 Composition for forming liquid crystal layer, liquid crystal display device, and method for producing liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2017-05-09 US claimed
US-20130169916-A1 COMPOSITION FOR FORMING LIQUID CRYSTAL LAYER, LIQUID CRYSTAL DISPLAY DEVICE, AND METHOD FOR PRODUCING LIQUID CRYSTAL DISPLAY DEVICE TOYO GOSEI CO., LTD. (JP) 2013-07-04 US claimed
US-20110164213-A1 ALIGNMENT FILM, ALIGNMENT FILM MATERIAL, LIQUID CRYSTAL DISPLAY DEVICE COMPRISING ALIGNMENT FILM, AND METHOD FOR MANUFACTURING SAME SHARP KABUSHIKI KAISHA (JP) 2011-07-07 US claimed
EP-2330458-A1 ALIGNMENT FILM, ALIGNMENT FILM MATERIAL, LIQUID CRYSTAL DISPLAY DEVICE COMPRISING ALIGNMENT FILM, AND METHOD FOR MANUFACTURING SAME Sharp Kabushiki Kaisha (JP) 2011-06-08 EP claimed
US-7534370-B2 Polymerizable liquid crystal composition, optical anisotropic material, optical element and optical head device ASAHI GLASS COMPANY, LIMITED (JP) 2009-05-19 US claimed
US-20080048149-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL, OPTICAL ELEMENT AND OPTICAL HEAD DEVICE ASAHI GLASS COMPANY, LIMITED (JP) 2008-02-28 US claimed
EP-1873228-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL, OPTICAL ELEMENT, AND OPTICAL HEAD DEVICE Asahi Glass Company, Limited (JP) 2008-01-02 EP claimed
EP-1071667-A4 RECEPTOR LIGANDS SMITHKLINE BEECHAM CORP (US) 2004-10-20 EP claimed
US-20010016569-A1 Receptor ligands SMITHKLINE BEECHAM CORPORATION 2001-08-23 US claimed
EP-1071667-A1 RECEPTOR LIGANDS SMITHKLINE BEECHAM CORPORATION (US) 2001-01-31 EP claimed
WO-1999052877-A1 RECEPTOR LIGANDS SMITHKLINE BEECHAM CORPORATION (US) 1999-10-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010016569-A1 Receptor ligands FCER2, FCGR2A, FCGR1A CYP2A6 4087/4885ALOX12 2842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.